Trials / Unknown
UnknownNCT04934410
Induction Agent and Incidence of Hypotension in Heart Failure Patients Undergoing LVAD-Implantation
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Heidelberg University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The induction of anesthesia is one of the most critical situations for high-risk-patients undergoing major surgery. For several reasons, it is crucial to maintain adequate blood pressure and cardiac output during this phase. This observational study aims to find out if the choice of the induction agent has a major impact on blood pressure and the use of antihypotensive drugs during the induction and the surgical procedure in heart-failure patients undergoing the implantation of a left ventricular assist device (LVAD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Etomidate | Use of etomidate during induction as decided by attending anesthesiologist |
| DRUG | Midazolam | Use of midazolam during induction as decided by attending anesthesiologist |
| DRUG | Sevoflurane | Use of sevoflurane during induction as decided by attending anesthesiologist |
Timeline
- Start date
- 2021-11-01
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2021-06-22
- Last updated
- 2021-10-19
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04934410. Inclusion in this directory is not an endorsement.